Association between Mycobacterium tuberculosis lineage and time to sputum culture conversion

International Journal of Tuberculosis and Lung Disease

Volumn 17, Issue 7, 2013, Pages 878-884

  Click, Eleanor S ^a   Winston, C A ^a   Oeltmann, J E ^a   Moonan, P K ^a   Mac Kenzie, W R ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Drug tolerance; Molecular epidemiology; Treatment

Indexed keywords

ANTIBIOTIC RESISTANCE; ARTICLE; COHORT ANALYSIS; EAST AFRICAN INDIAN; EAST ASIAN; ETHNIC DIFFERENCE; ETHNIC GROUP; EURO AMERICAN; GENETIC LINE; HUMAN; INDO OCCEANIC; LABORATORY DIAGNOSIS; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SPUTUM CULTURE; SPUTUM SMEAR; TREATMENT RESPONSE; TUBERCULOSIS CONTROL; UNITED STATES;

ANTITUBERCULAR AGENTS; BACTERIAL TYPING TECHNIQUES; COHORT STUDIES; DRUG RESISTANCE, BACTERIAL; DRUG THERAPY, COMBINATION; GENOTYPE; HUMANS; MYCOBACTERIUM TUBERCULOSIS; RETROSPECTIVE STUDIES; SPUTUM; TIME FACTORS; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY; UNITED STATES;

EID: 84878905587     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.12.0732     Document Type: Article

References (36)

1. Gagneux S, Small P M. Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development. Lancet Infect Dis 2007; 7: 328-337. (Pubitemid 46590063)
2. Coscolla M, Gagneux S. Does M. tuberculosis genomic diversity explain disease diversity? Drug Discov Today Dis Mech 2011; 7: e43-e59.
3. Nicol M P, Wilkinson R J. The clinical consequences of strain diversity in Mycobacterium tuberculosis. Trans R Soc Trop Med Hyg 2008; 102: 955-965.
4. Salihu H M, Aliyu M H, Ratard R, Pierre-Louis B J. Characteristics associated with reported sputum culture conversion in the era of re-emergent Mycobacterium tuberculosis in the State of North Carolina, 1993-1998. Int J Tuberc Lung Dis 2003; 7: 1070-1076. (Pubitemid 37376958)
5. Fitzwater S P, Caviedes L, Gilman R H, et al. Prolonged infectiousness of tuberculosis patients in a directly observed therapy short-course program with standardized therapy. Clin Infect Dis 2010; 51: 371-378.
6. Horne D J, Johnson C O, Oren E, Spitters C, Narita M. How soon should patients with smear-positive tuberculosis be released from inpatient isolation? Infect Control Hosp Epidemiol 2010; 31: 78-84.
7. Jeremiah K, Praygod G, Faurholt-Jepsen D, et al. BCG vaccination status may predict sputum conversion in patients with pulmonary tuberculosis: a new consideration for an old vaccine? Thorax 2010; 65: 1072-1076.
8. Dooley K E, Tang T, Golub J E, Dorman S E, Cronin W. Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis. Am J Trop Med Hyg 2009; 80: 634-639.
9. Hesseling A C, Walzl G, Enarson D A, et al. Baseline sputum time to detection predicts month two culture conversion and relapse in non-HIV-infected patients. Int J Tuberc Lung Dis 2010; 14: 560-570.
10. Guler M, Unsal E, Dursun B, Aydln O, Capan N. Factors influencing sputum smear and culture conversion time among patients with new case pulmonary tuberculosis. Int J Clin Pract 2007; 61: 231-235.
11. Aliyu M H, Salihu H M, Ratard R. HIV infection and sputumculture conversion in patients diagnosed with Mycobacterium tuberculosis: a population-based study. Wien Klin Wochenschr 2003; 115: 340-346. (Pubitemid 36753063)
12. Gopi P G, Chandrasekaran V, Subramani R, et al. Association of conversion and cure with initial smear grading among new smear positive pulmonary tuberculosis patients treated with Category I regimen. Indian J Med Res 2006; 123: 807-814. (Pubitemid 44269948)
13. Abal A T, Jayakrishnan B, Parwer S, El Shamy A, Abahussain E, Sharma P N. Effect of cigarette smoking on sputum smear conversion in adults with active pulmonary tuberculosis. Respir Med 2005; 99: 415-420. (Pubitemid 40347824)
14. Wang J Y, Lee L N, Yu C J, Chien Y J, Yang P C. Factors influencing time to smear conversion in patients with smearp ositive pulmonary tuberculosis. Respirology 2009; 14: 1012-1019.
15. Nahid P, Bliven E E, Kim E Y, et al. Influence of M. tuberculosis lineage variability within a clinical trial for pulmonary tuberculosis. PLoS ONE 2010; 5: e10753.
16. Burman W J, Bliven E E, Cowan L, et al. Relapse associated with active disease caused by Beijing strain of Mycobacterium tuberculosis. Emerg Infect Dis 2009; 15: 1061-1067.
17. Centers for Disease Control and Prevention. Reported tuberculosis in the United States, 2010. Atlanta, GA, USA: US Department of Health and Human Services, CDC, 2010.
18. Click E S, Moonan P K, Winston C A, Cowan L S, Oeltmann J E. Relationship between Mycobacterium tuberculosis phylogenetic lineage and clinical site of tuberculosis. Clin Infect Dis 2012; 54: 211-219.
19. Kato-Maeda M, Gagneux S, Flores L L, et al. Strain classification of Mycobacterium tuberculosis: congruence between large sequence polymorphisms and spoligotypes. Int J Tuberc Lung Dis 2011; 15: 131-133.
20. Shabbeer A, Cowan L S, Ozcaglar C, et al. TB-Lineage: an online tool for classification and analysis of strains of Mycobacterium tuberculosis complex. Infect Genet Evol 2012; 12: 789-797.
21. Chang K C, Yew W W, Zhang Y. Pyrazinamide susceptibility testing in Mycobacterium tuberculosis: a systematic review with meta-analyses. Antimicrob Agents Chemother 2011; 55: 4499-4505.
22. Centers for Disease Control and Prevention. Report of Verified Case of Tuberculosis form completion instructions. Atlanta, GA, USA: CDC, 2009. http://www.cdc.gov/tb/programs/rvct/InstructionManual.pdf Accessed March 2013.
23. Centers for Disease Control and Prevention. National TB program objectives and performance targets for 2015. Atlanta, GA, USA: 2010. http://www.cdc.gov/tb/programs/Evaluation/Indicators/default.htm Accessed March 2013.
24. Ma Z, Lienhardt C, McIlleron H, Nunn A J, Wang X. Global tuberculosis drug development pipeline: the need and the reality. Lancet 2010; 375: 2100-2109.
25. Blumberg H M, Burman W J, Chaisson R E, et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 2003; 167: 603-662.
26. World Health Organization. WHO report 2010. Global tuberculosis control. WHO/HTM/TB/2010.7. Geneva, Switzerland: WHO, 2010.
27. Narayanan S, Gagneux S, Hari L, et al. Genomic interrogation of ancestral Mycobacterium tuberculosis from South India. Infect Genet Evol 2008; 8: 474-483. (Pubitemid 351682376)
28. Mitchison D A, Wallace J G, Bhatia A L, Selkon J B, Subbaiah T V, Lancaster M C. A comparison of the virulence in guineapigs of South Indian and British tubercle bacilli. Tubercle 1960; 41: 1-22.
29. Brosch R, Gordon S V, Marmiesse M, et al. A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proc Natl Acad Sci USA 2002; 99: 3684-3689. (Pubitemid 34252166)
30. Stucki D, Malla B, Hostettler S, et al. Two new rapid SNP-typing methods for classifying Mycobacterium tuberculosis complex into the main phylogenetic lineages. PLoS ONE 2012; 7: e41253.
31. Comas I, Chakravartti J, Small P M, et al. Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved. Nat Genet 2010; 42: 498-503.
32. de Jong B C, Onipede A, Pym A S, et al. Does resistance to pyrazinamide accurately indicate the presence of Mycobacterium bovis? J Clin Microbiol 2005; 43: 3530-3532. (Pubitemid 40981386)
33. Brudey K, Driscoll J R, Rigouts L, et al. Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. BMC Microbiol 2006; 6: 23.
34. Krishnan N, Malaga W, Constant P, et al. Mycobacterium tuberculosis lineage influences innate immune response and virulence and is associated with distinct cell envelope lipid profiles. PLoS ONE 2011; 6: e23870.
35. Homolka S, Niemann S, Russell D G, Rohde K H. Functional genetic diversity among Mycobacterium tuberculosis complex clinical isolates: delineation of conserved core and lineages pecific transcriptomes during intracellular survival. PLoS Pathog 2010; 6: e1000988.
36. Portevin D, Gagneux S, Comas I, Young D. Human macrophage responses to clinical isolates from the Mycobacterium tuberculosis complex discriminate between ancient and modern lineages. PLoS Pathog 2011; 7: e1001307.